HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab.

Abstract
Radioimmunotherapy involves the use of radiolabeled monoclonal antibodies (MAbs) to treat malignancy. The therapeutic effect is determined by the radiopharmaceutical, the radiation absorbed dose and previous treatments. There are currently two approved radiopharmaceuticals for the treatment of B-cell lymphoma - the (90)Y-labeled ibritumomab and the (131)I-labeled tositumomab. Both are directed against CD20, albeit not against the same epitope. This paper summarizes current results of dose-responses for normal tissues and tumours of [(131)I]tositumomab and [(90)Y]ibritumomab tiuxetan, discusses them in the context of dosimetry methods used and highlights the assumptions being made in the different dosimetry methodologies. Moreover, we wish to point at the possibility of performing low-cost therapy bremsstrahlung imaging for [(90)Y]ibritumomab tiuxetan to confirm biodistribution, and possibly also for dosimetric calculations.
AuthorsK Sjögreen-Gleisner, Y K Dewaraja, C Chiesa, J Tennvall, O Lindén, S E Strand, M Ljungberg
JournalThe quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... (Q J Nucl Med Mol Imaging) Vol. 55 Issue 2 Pg. 126-54 (Apr 2011) ISSN: 1824-4785 [Print] Italy
PMID21386787 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD20
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Yttrium Radioisotopes
  • ibritumomab tiuxetan
  • tositumomab I-131
Topics
  • Antibodies, Monoclonal (administration & dosage, pharmacokinetics, therapeutic use)
  • Antigens, CD20 (metabolism)
  • Bone Marrow (radiation effects)
  • Dose-Response Relationship, Radiation
  • Female
  • Humans
  • Iodine Radioisotopes (administration & dosage, therapeutic use)
  • Lymphoma, B-Cell (diagnostic imaging, immunology, radiotherapy)
  • Male
  • Radioimmunotherapy (methods)
  • Radiopharmaceuticals (administration & dosage, pharmacokinetics, therapeutic use)
  • Radiotherapy Planning, Computer-Assisted
  • Tomography, Emission-Computed, Single-Photon
  • Tomography, X-Ray Computed
  • Yttrium Radioisotopes (administration & dosage, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: